Dare Bioscience, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Dare Bioscience, Inc. (DARE) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-26
- Dare Bioscience, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.70%.
- Dare Bioscience, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -12.88%.
- Dare Bioscience, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was 0.00%.
- Dare Bioscience, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was 0.00%, a 100.00% decline from fiscal 2015.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.70% 10-K · filed 2026-03-26 | |
| 2024-12-31 | -12.88% 10-K · filed 2026-03-26 | |
| 2017-12-31 | 0.00% 10-K · filed 2018-03-28 | |
| 2016-12-31 | 0.00% 10-K · filed 2018-03-28 | 0.20% 10-K · filed 2017-03-31 |
| 2015-12-31 | 0.40% 10-K/A · filed 2017-06-13 | |
| 2014-12-31 | -0.80% 10-K · filed 2016-03-10 | |
| 2013-12-31 | 0.20% 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |